FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis

Authorized Users Only
2004
Authors
Radenković, D
Bajec, D
Karamarković, A
Stefanović, B
Milić, N
Ignjatović, Svetlana
Gregorić, P
Milicević, M
Article (Published version)
Metadata
Show full item record
Abstract
Objectives: Several clinical studies of severe necrotizing pancreatitis ( SNP) suggest profound activation of coagulation as well as activation of the fibrinolytic system. The aim of this study was to evaluate the hemostatic derangements in patients who were managed for SNP. Methods: Forty-one operated-on patients with SNP were analyzed regarding clinical outcome and activation of the coagulation systems. Serial measurement of coagulation, anticoagulation, and fibrinolysis parameters: prothrombin time ( PT), activated partial thromboplastin time (APTT), fibrinogen, antithrombin III ( AT III), protein C, plasminogen activator inhibitor-1 (PAI-1), D-dimer, alpha(2)-antiplasmin, and plasminogen were performed on days 1, 3, 5, 7, 10, and 14 after the initial operation. According to treatment outcome at the end of study, groups of 26 survivors and 15 nonsurvivors were compared. Results: Nonsurvivors had significantly lower levels of activity of protein C and AT III, and higher concentration...s of D-dimer and PAI-1 than survivors. The other measured parameters did not show significant differences between the compared groups of patients. Conclusions: Changes in protein C, AT III, D-dimer and PAI-1 levels indicate exhaustion of fibrinolysis and coagulation inhibitors in patients with poor outcome during the course of SNP.

Keywords:
acute pancreatitis / disorders of hemostasis / protein C-antithrombin III / D-dimer / plasminogen activator inhibitor-1
Source:
Pancreas, 2004, 29, 2, 152-156
Publisher:
  • Lippincott Williams & Wilkins, Philadelphia

DOI: 10.1097/00006676-200408000-00010

ISSN: 0885-3177

PubMed: 15257107

WoS: 000224458000010

Scopus: 2-s2.0-3242744594
[ Google Scholar ]
36
30
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/513
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Radenković, D
AU  - Bajec, D
AU  - Karamarković, A
AU  - Stefanović, B
AU  - Milić, N
AU  - Ignjatović, Svetlana
AU  - Gregorić, P
AU  - Milicević, M
PY  - 2004
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/513
AB  - Objectives: Several clinical studies of severe necrotizing pancreatitis ( SNP) suggest profound activation of coagulation as well as activation of the fibrinolytic system. The aim of this study was to evaluate the hemostatic derangements in patients who were managed for SNP. Methods: Forty-one operated-on patients with SNP were analyzed regarding clinical outcome and activation of the coagulation systems. Serial measurement of coagulation, anticoagulation, and fibrinolysis parameters: prothrombin time ( PT), activated partial thromboplastin time (APTT), fibrinogen, antithrombin III ( AT III), protein C, plasminogen activator inhibitor-1 (PAI-1), D-dimer, alpha(2)-antiplasmin, and plasminogen were performed on days 1, 3, 5, 7, 10, and 14 after the initial operation. According to treatment outcome at the end of study, groups of 26 survivors and 15 nonsurvivors were compared. Results: Nonsurvivors had significantly lower levels of activity of protein C and AT III, and higher concentrations of D-dimer and PAI-1 than survivors. The other measured parameters did not show significant differences between the compared groups of patients. Conclusions: Changes in protein C, AT III, D-dimer and PAI-1 levels indicate exhaustion of fibrinolysis and coagulation inhibitors in patients with poor outcome during the course of SNP.
PB  - Lippincott Williams & Wilkins, Philadelphia
T2  - Pancreas
T1  - Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis
VL  - 29
IS  - 2
SP  - 152
EP  - 156
DO  - 10.1097/00006676-200408000-00010
ER  - 
@article{
author = "Radenković, D and Bajec, D and Karamarković, A and Stefanović, B and Milić, N and Ignjatović, Svetlana and Gregorić, P and Milicević, M",
year = "2004",
abstract = "Objectives: Several clinical studies of severe necrotizing pancreatitis ( SNP) suggest profound activation of coagulation as well as activation of the fibrinolytic system. The aim of this study was to evaluate the hemostatic derangements in patients who were managed for SNP. Methods: Forty-one operated-on patients with SNP were analyzed regarding clinical outcome and activation of the coagulation systems. Serial measurement of coagulation, anticoagulation, and fibrinolysis parameters: prothrombin time ( PT), activated partial thromboplastin time (APTT), fibrinogen, antithrombin III ( AT III), protein C, plasminogen activator inhibitor-1 (PAI-1), D-dimer, alpha(2)-antiplasmin, and plasminogen were performed on days 1, 3, 5, 7, 10, and 14 after the initial operation. According to treatment outcome at the end of study, groups of 26 survivors and 15 nonsurvivors were compared. Results: Nonsurvivors had significantly lower levels of activity of protein C and AT III, and higher concentrations of D-dimer and PAI-1 than survivors. The other measured parameters did not show significant differences between the compared groups of patients. Conclusions: Changes in protein C, AT III, D-dimer and PAI-1 levels indicate exhaustion of fibrinolysis and coagulation inhibitors in patients with poor outcome during the course of SNP.",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Pancreas",
title = "Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis",
volume = "29",
number = "2",
pages = "152-156",
doi = "10.1097/00006676-200408000-00010"
}
Radenković, D., Bajec, D., Karamarković, A., Stefanović, B., Milić, N., Ignjatović, S., Gregorić, P.,& Milicević, M.. (2004). Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis. in Pancreas
Lippincott Williams & Wilkins, Philadelphia., 29(2), 152-156.
https://doi.org/10.1097/00006676-200408000-00010
Radenković D, Bajec D, Karamarković A, Stefanović B, Milić N, Ignjatović S, Gregorić P, Milicević M. Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis. in Pancreas. 2004;29(2):152-156.
doi:10.1097/00006676-200408000-00010 .
Radenković, D, Bajec, D, Karamarković, A, Stefanović, B, Milić, N, Ignjatović, Svetlana, Gregorić, P, Milicević, M, "Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis" in Pancreas, 29, no. 2 (2004):152-156,
https://doi.org/10.1097/00006676-200408000-00010 . .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB